Results
|
|
12881.
|
|
|
|
12882.
|
|
|
|
12883.
|
|
|
|
12884.
|
|
|
|
12885.
|
|
|
|
12886.
|
|
|
|
12887.
|
|
|
|
12888.
|
|
|
|
12889.
|
|
|
|
12890.
|
|
|
|
12891.
|
|
|
|
12892.
|
|
|
|
12893.
|
|
|
|
12894.
|
|
|
|
12895.
|
|
|
|
12896.
|
|
|
|
12897.
|
|
|
|
12898.
|
|
|
|
12899.
|
|
|
|
12900.
|
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study. [electronic resource] by
- Ali, Shehzad
- Paracha, Noman
- Cook, Stuart
- Giovannoni, Gavin
- Comi, Giancarlo
- Rammohan, Kottil
- Rieckmann, Peter
- Sørensen, Per Soelberg
- Vermersch, Patrick
- Greenberg, Steven
- Scott, David A
- Joyeux, Alexandre
Producer: 20120403
In:
Clinical drug investigation vol. 32
Availability: No items available.
|